Generic name:buprenorphine/naloxone (oromucosal route, sublingual route) [ bue-pre-NOR-feen, nal-OX-one ]
Drug class:Narcotic analgesic combinations
Medically reviewed by Drugs.com. Last updated on Apr 30, 2022.
The Cassipa brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Commonly used brand name(s)
In the U.S.
- Cassipa
- Suboxone
- Zubsolv
Available Dosage Forms:
- Tablet
- Film
Therapeutic Class: Opioid Dependency
Pharmacologic Class: Opioid Agonist/Antagonist
Chemical Class: Opioid
Uses for Cassipa
Buprenorphine and naloxone sublingual tablet is used to treat opioid (narcotic) dependence or addiction. Buprenorphine and naloxone buccal film, sublingual film, or sublingual tablet is used for induction and maintenance treatment of opioid (narcotic) dependence. It should be used in patients who have already been treated with buprenorphine sublingual tablets.
When a narcotic medicine is used for a long time, it may become habit-forming, causing mental or physical dependence. Physical dependence may lead to withdrawal side effects if the narcotic is stopped suddenly. Severe withdrawal side effects can usually be prevented when a person is switched to buprenorphine and naloxone combination. It acts on the central nervous system (CNS) to help prevent the withdrawal side effects.
This medicine is available only with your doctor's prescription.
Before using Cassipa
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or...
